Alkermes (ALKS) Total Liabilities (2011 - 2026)

Alkermes' (ALKS) quarterly Total Liabilities came in at $2.5 billion in Q1 2026, up 339.44% year-on-year from $570.4 million in Q1 2025, and up 275.4% on a QoQ basis from $667.7 million in Q4 2025.

Alkermes (ALKS) Total Liabilities (2011 - 2026) Analysis & Trends

Alkermes (ALKS) has 16 years of Total Liabilities data on file, last reported at $2.5 billion in Q1 2026.

  • On a quarterly basis, Total Liabilities rose 339.44% year-over-year to $2.5 billion in Q1 2026; TTM through Mar 2026 was $2.5 billion, a 339.44% increase from a year earlier, with the FY2025 full-year figure at $667.7 million, up 13.06% from the prior year.
  • Total Liabilities for Q1 2026 stood at $2.5 billion, up from $667.7 million in the prior quarter.
  • Over the last five years, Total Liabilities for ALKS reached as high as $2.5 billion in Q1 2026 and fell as low as $570.4 million in Q1 2025.
  • Historically, Total Liabilities has averaged $911.3 million across 5 years, with a median of $899.0 million in 2022.
  • Across the five-year window, Total Liabilities tumbled 36.74% in 2024 and surged 339.44% in 2026, its largest moves.
  • Year by year, Total Liabilities stood at $920.2 million in 2022, then gained by 1.45% to $933.5 million in 2023, then tumbled by 36.74% to $590.6 million in 2024, then climbed by 13.06% to $667.7 million in 2025, then soared by 275.4% to $2.5 billion in 2026.
  • Per Business Quant data, the three most recent Total Liabilities figures were $2.5 billion in Q1 2026, $667.7 million in Q4 2025, and $596.1 million in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Liabilities (Qtr)
1 Haleon 87.22 Bn 85.35 Bn - 21.48 Bn
2 Teva Pharmaceutical Industries 39.60 Bn 35.87 Bn 1.97 Bn 31.81 Bn
3 Zoetis 31.46 Bn 29.52 Bn 1.62 Bn 11.92 Bn
4 Takeda Pharmaceutical 26.49 Bn 22.44 Bn 4.39 Bn 51.53 Bn
5 United Therapeutics 23.03 Bn 20.88 Bn 648.10 Mn 813.10 Mn
6 Universe Pharmaceuticals 23.03 Bn -10.56 Bn - 13.17 Bn
7 Viatris 20.90 Bn 19.09 Bn 1.16 Bn 22.18 Bn
8 Neurocrine Biosciences 17.50 Bn 16.19 Bn 800.70 Mn 1.50 Bn
9 Elanco Animal Health 12.33 Bn 11.91 Bn 785.00 Mn 6.72 Bn
10 Alkermes 9.72 Bn 9.21 Bn 331.33 Mn 2.51 Bn

Historic Data

Download Data
DateValue
Mar 31, 2026 2.51 Bn
Dec 31, 2025 667.70 Mn
Sep 30, 2025 596.08 Mn
Jun 30, 2025 628.23 Mn
Mar 31, 2025 570.39 Mn
Dec 31, 2024 590.59 Mn
Sep 30, 2024 863.19 Mn
Jun 30, 2024 922.84 Mn
Mar 31, 2024 869.13 Mn
Dec 31, 2023 933.54 Mn
Sep 30, 2023 923.65 Mn
Jun 30, 2023 906.75 Mn
Mar 31, 2023 917.15 Mn
Dec 31, 2022 920.23 Mn
Sep 30, 2022 899.05 Mn
Jun 30, 2022 875.09 Mn
Mar 31, 2022 902.46 Mn
Dec 31, 2021 911.90 Mn
Sep 30, 2021 899.26 Mn
Jun 30, 2021 839.67 Mn